| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |